These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29365085)

  • 1. Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks.
    Mehlum MH; Liestøl K; Kjeldsen SE; Julius S; Hua TA; Rothwell PM; Mancia G; Parati G; Weber MA; Berge E
    Eur Heart J; 2018 Jun; 39(24):2243-2251. PubMed ID: 29365085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers.
    Mehlum MH; Liestøl K; Kjeldsen SE; Wyller TB; Julius S; Rothwell PM; Mancia G; Parati G; Weber MA; Berge E
    Hypertension; 2020 Jun; 75(6):1584-1592. PubMed ID: 32336236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
    Thune JJ; Signorovitch J; Kober L; Velazquez EJ; McMurray JJ; Califf RM; Maggioni AP; Rouleau JL; Howlett J; Zelenkofske S; Pfeffer MA; Solomon SD
    Hypertension; 2008 Jan; 51(1):48-54. PubMed ID: 18025296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy.
    Vishram JK; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Mancia G; Okin PM; Rothwell PM; Wachtell K; Olsen MH
    J Hypertens; 2015 Dec; 33(12):2422-30. PubMed ID: 26378687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population.
    Pringle E; Phillips C; Thijs L; Davidson C; Staessen JA; de Leeuw PW; Jaaskivi M; Nachev C; Parati G; O'Brien ET; Tuomilehto J; Webster J; Bulpitt CJ; Fagard RH;
    J Hypertens; 2003 Dec; 21(12):2251-7. PubMed ID: 14654744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Mancia G; Kjeldsen SE; Zappe DH; Holzhauer B; Hua TA; Zanchetti A; Julius S; Weber MA
    Eur Heart J; 2016 Mar; 37(12):955-64. PubMed ID: 26590384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study.
    Rodriguez CJ; Swett K; Agarwal SK; Folsom AR; Fox ER; Loehr LR; Ni H; Rosamond WD; Chang PP
    JAMA Intern Med; 2014 Aug; 174(8):1252-61. PubMed ID: 24935209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of valsartan and amlodipine on home blood pressure and cardiovascular events in Japanese hypertensive patients: a subanalysis of the VART.
    Takano H; Hasegawa H; Narumi H; Shindo S; Mizuma H; Kuwabara Y; Kobayashi Y; Komuro I;
    J Hum Hypertens; 2012 Nov; 26(11):656-63. PubMed ID: 21993491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension.
    Julius S; Palatini P; Kjeldsen SE; Zanchetti A; Weber MA; McInnes GT; Brunner HR; Mancia G; Schork MA; Hua TA; Holzhauer B; Zappe D; Majahalme S; Jamerson K; Koylan N
    Am J Cardiol; 2012 Mar; 109(5):685-92. PubMed ID: 22169130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of amlodipine versus other calcium channel blockers on blood pressure variability in hypertensive patients in China: a retrospective propensity score-matched analysis.
    Zhang L; Yang J; Li L; Liu D; Xie X; Dong P; Lin Y
    J Comp Eff Res; 2018 Jul; 7(7):651-660. PubMed ID: 29888950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial.
    Bangalore S; Fayyad R; Messerli FH; Laskey R; DeMicco DA; Kastelein JJ; Waters DD
    Am J Cardiol; 2017 Feb; 119(3):379-387. PubMed ID: 27939230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.
    Whittle J; Lynch AI; Tanner RM; Simpson LM; Davis BR; Rahman M; Whelton PK; Oparil S; Muntner P
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):471-80. PubMed ID: 26912544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial.
    Gupta A; Whiteley WN; Godec T; Rostamian S; Ariti C; Mackay J; Whitehouse A; Janani L; Poulter NR; Sever PS;
    Eur Heart J; 2024 Apr; 45(13):1159-1169. PubMed ID: 38291599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study.
    Ohkuma T; Woodward M; Jun M; Muntner P; Hata J; Colagiuri S; Harrap S; Mancia G; Poulter N; Williams B; Rothwell P; Chalmers J;
    Hypertension; 2017 Aug; 70(2):461-468. PubMed ID: 28584014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE Trial.
    Vrsalovic M; Heimark S; Søraas CL; Mehlum MH; Kjeldsen SE; Mancia G; Julius S; Weber MA
    Hypertension; 2024 Jul; 81(7):1628-1636. PubMed ID: 38716657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial.
    Mehlum MH; Liestøl K; Wyller TB; Hua TA; Rostrup M; Berge E
    Blood Press; 2019 Apr; 28(2):77-83. PubMed ID: 30614275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
    Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
    Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visit-to-Visit Blood Pressure Variability and Mortality and Cardiovascular Outcomes Among Older Adults: The Health, Aging, and Body Composition Study.
    Wu C; Shlipak MG; Stawski RS; Peralta CA; Psaty BM; Harris TB; Satterfield S; Shiroma EJ; Newman AB; Odden MC;
    Am J Hypertens; 2017 Feb; 30(2):151-158. PubMed ID: 27600581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.